20936 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
Lipocalin fusion partners
#302Compositions and methods for topical diagnostic and therapeutic transport
#303METHODS FOR SCREENING
#304Cooperia vaccine
#305Hydrogels for delivery of therapeutic polypeptides
#306Carrier immunoglobulins and uses thereof
#307Substituted benzo[f]imidazo[1,2-a]quinoxalines and imidazo[1,2-a]pyrazines
#308PROBIOTIC BACTERIA AS CARRIER FOR A HELMINTH-DERIVED IMMUNOMODULATOR FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#309GLYCAN COMPOSITIONS, PROCESSES FOR PREPARING THE SAME AND THEIR USES AS A DRUG
#310Further preparations of silk proteins, seed oils, monosaccharide, natural botanicals and polysaccharide mixtures in compositions for hair care or hair repair, and skin care and topical treatments
#311Treatment of ischemia
#312EV576 for use in the treatment of viral infections of the respiratory tract
#313One component fibrin glue comprising zymogens
#314Pan-antiviral peptides and uses thereof
#315Cosmetic composition comprising a muconopeptide
#316Delivery of negatively charged proteins using cationic lipids
#317Anti-angiogenic treatment of endothelial tissue with a combination of antagonists
#318Immunostimulatory compositions and methods of manufacture
#319Delivery system for functional nucleases
#320Use of cationic lipids to deliver CAS9
#321Bacteriophages expressing antimicrobial peptides and uses thereof
#322COMBINATION THERAPIES USING LATE SODIUM ION CHANNEL BLOCKERS AND POTASSIUM ION CHANNEL BLOCKERS
#323OPHTHALMIC FORMULATION DERIVED FROM SILK PROTEIN
#324Antimicrobial Peptide Variants and Polynucleotides Encoding Same
#325Potent and selective inhibitors of NA1.7
#326Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
#327METHOD FOR ADMINISTERING OMEGA-CONOPEPTIDE
#328Modified epitopes for boosting CD4+ T-cell responses
#329COMPOSITION FOR TREATING PARKINSON'S DISEASE
#330Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis
#331METHODS AND COMPOSITIONS FOR ENHANCING CD4+ REGULATORY T CELLS
#332Methods comprising dosing combinations for reducing undesired humoral immune responses
#333Multipurpose gel for vaginal dryness with direct and delayed effect
#334Injectable silk fibroin foams and uses thereof
#335APOAEQUORIN FOR REDUCING NEURONAL INJURY DUE TO ISCHEMIA
#336Treatment of muscular conditions and muscular dystrophies
#337OPHTHALMIC FORMULATION DERIVED FROM SILK PROTEIN
#338SHK-based pharmaceutical compositions and methods of manufacturing and using the same
#339Cancer therapy method
#340SILK COMPOSITIONS AND METHODS OF USING SAME
#341Peptide toxin formulation
#342Method for administering omega-conopeptide
#343Formulation for treatment of dry mouth and mouth sores
#344Biomaterial of chymotryptically isolated fraction of fibroin in a hydrogel
#345Skin formulation, preparation and uses thereof
#346Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#347Treatment of proliferative disorders with a chemiluminescent agent
#348Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
#349Method for administering omega-conopeptide
#350FORMULATIONS HAVING AN ALPHA V BETA 3 ANTAGONIST AND AN ALPHA 2 BETA 1 ANTAGONIST FOR ANTI-ANGIONIC THERAPY
#351Standardized bee venom preparation
#352Mu-conotoxin peptides and use thereof as a local anesthetic
#353Silk fibroin hydrogels and uses thereof
#354Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof
#355PHOSPHOLIPID AND PROTEIN TABLETS
#356Administration of an antagonist of α5β1 for anti-angiogenesis and cancer treatment
#357Dendritic cell inhibitory proteins from ticks
#358Pharmaceutical formulation for reducing pain
#359Skin formulation, preparation and uses thereof
#360Treatment of metastatic tumors
#361Peptide toxin formulation
#362EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT
#363Compositions and soft tissue replacement methods
#364SILK FIBROIN HYDROGELS AND USES THEREOF
#365Compositions and soft tissue replacement methods
#366Compositions and soft tissue replacement methods
#367Compositions and soft tissue replacement methods
#368Methods and compound to inhibit Ca permeable cation conductance
#369Silk fibroin hydrogels and uses thereof
#370SILK FIBROIN HYDROGELS AND USES THEREOF
#371SILK FIBROIN HYDROGELS AND USES THEREOF
#372Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
#373Nanoparticle delivery systems for membrane-integrating peptides
#374Mu-Conotoxin Peptides and Use Thereof as a Local Anesthetic
#375Treatment of ischemia
#376POLARIZED SCORPION VENOM SOLUTION AND A METHOD FOR MAKING POLARIZED SCORPION VENOM SOLUTION
#377COMPOSITION COMPRISING THE PURIFIED EXTRACT OF BEE VENOM FOR PREVENTING AND TREATING DEGENERATIVE BRAIN DISEASE
#378DENDRITIC CELL MODULATORY MOLECULE
#379Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
#380Method for reducing pain
#381COMBINED ADMINISTRATION OF INTEGRIN RECEPTOR ANTAGONISTS FOR ANTI-ANGIOGENIC THERAPY
#382Further preparations of silk proteins, seed oils, monosaccharide, natural botanicals and polysaccharide mixtures in compositions for hair care or hair repair, and skin care and topical treatments
#383Antimicrobial peptide variants and polynucleotides encoding same
#384Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia
#385Methods, systems and devices for optical stimulation of target cells using an optical transmission element
#386Compositions and methods for promoting wound healing and tissue regeneration
#387Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition
#388Inhibition of angiogenesis
#389Conjugate comprising P21 protein for the treatment of cancer
#390Method for reducing pain with ziconotide and baclofen
#391Method for reducing pain with ziconotide and morphine
#392Silk Fibroin Hydrogels and Uses Thereof
#393Silk Fibroin Hydrogels and Uses Thereof
#394Silk fibroin hydrogels and uses thereof
#395Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers
#396Silk Fibroin Hydrogels and Uses Thereof
#397Silk Fibroin Hydrogels and Uses Thereof
#398Silk Fibroin Hydrogels and Uses Thereof
#399TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#400Compositions comprising fibrous polypeptides and polysaccharides
#401Stable amorphous calcium carbonate comprising phosphorylated amino acids
#402PROCESS FOR PRODUCTION OF BIVALIRUDIN
#403STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES
#404Use of epinecidin-1 peptides and anti-lipopolysaccharide factor peptides for treating microbial infection
#405Method of treating peripheral nerve disorders
#406ANTIBIOTIC SYNERGISM
#407Peptide toxin formulation
#408Adiponectin production enhancer
#409PROCESS FOR PRODUCTION OF BIVALIRUDIN
#410Treatment of metastatic tumors
#411Pharmaceutical formulations for reducing pain
#412Methods for inhibiting CLC-2 channel with GATX2
#413Compositions and methods for promoting wound healing and tissue regeneration
#414Apparatus and Methods for Treating Epilepsy Using Convection-Enhanced Delivery
#415Method of treating myasthenia gravis
#416Methods for treating pain and screening analgesic compounds
#417Polarized scorpion venom solution and a method for making polarized scorpion venom solution
#418Compositions and methods for promoting lipid mobilization in humans
#419Conjugate Comprising P21 Protein for the Treatment of Cancer
#420Nanoparticle delivery systems comprising a hydrophobic core and a lipid/surfactant layer comprising a membrane-lytic peptide
#421Standardized bee venom preparation
#422Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
#423METHODS FOR MODULATING A DRUG-RELATED EFFECT OR BEHAVIOR
#424Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers
#425Pan-antiviral peptides
#426ADDING MICROSCOPIC POROSITY TO THE SURFACE OF A MICROCOIL TO BE USED FOR MEDICAL IMPLANTATION
#427BIODEGRADABLE BIOPOLYMERS, METHOD FOR THEIR PREPARATION AND FUNCTIONAL MATERIALS CONSTITUTED BY THESE BIOPOLYMERS
#428BIODEGRADABLE BIOPOLYMERS, METHOD FOR THEIR PREPARATION AND FUNCTIONAL MATERIALS CONSTITUTED BY THESE BIOPOLYMERS
#429Composition and methods for promoting wound healing and tissue regeneration
#430Kappam-conopeptides as organ protectants
#431Compositions and methods for topical diagnostic and therapeutic transport
#432Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
#433Use of polypeptides in treating tissue injury
#434METHOD FOR REDUCING PAIN
#435Pharmaceutical formulation comprising ziconotide
#436Treatment of ischemia
#437Process for production of Bivalirudin
#438Skin rejuvinating supplement
#439Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
#440Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
#441Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
#442Compositions and methods for topical diagnostic and therapeutic transport
#443Method for reducing pain
#444Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120
#445Specific mechanism for inhibiting platelet adhesion to collagen
#446Child's cleaning implement comprising a biological extract
#447Methods for modulating a drug-related effect or behavior
#448Food compositions containing added honey proteins
#449Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
#450Use of Scleritine as agent for protecting cells against toxic agents
#451Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin